Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Biogen's Big Risk?

TheMotleyFool

0 0

Biogen (NASDAQ: BIIB), one of the world's leading biopharma companies, generates billions of dollars in sales every quarter. But I'm increasingly concerned that headwinds facing its top-selling multiple sclerosis drugs will weigh down sales growth in the future. Can Biogen overcome this risk to its revenue?

The MS drug market is worth $20 billion annually, and Biogen is the Goliath in the market, with a 38% market share.

IMAGE SOURCE: GETTY IMAGES.

Source: Fool.com

Like: 0

RHHBY

Share